Eflornithine
Showing 1 - 25 of 46
Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine
Recruiting
- Glioblastoma, IDH-wildtype
- +4 more
- Eflornithine (Dose Level 1)
- +3 more
-
Cleveland, OhioThe Cleveland Clinic
May 19, 2023
Gastric Cancer, Gastric Intestinal Metaplasia Trial in Copán, San Juan (Eflornithine, Eflornithine )
Active, not recruiting
- Gastric Cancer
- Gastric Intestinal Metaplasia
- Eflornithine
- Eflornithine placebo
-
Copán, Honduras
- +1 more
Aug 17, 2022
Neuroblastoma Trial in Canada, United States (Eflornithine)
Recruiting
- Neuroblastoma
- Eflornithine
-
Little Rock, Arkansas
- +22 more
Jan 23, 2023
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Familial Adenomatous Polyposis Trial in Worldwide (Eflornithine, Eflornithine Placebo, Sulindac 150 MG)
Completed
- Familial Adenomatous Polyposis
- Eflornithine
- +3 more
-
La Jolla, California
- +16 more
May 12, 2021
Neuroblastoma, Medulloblastoma, Typical Teratoid Rhabdoid Tumor Trial in Charlotte (eflornithine HCl)
No longer available
- Neuroblastoma
- +5 more
- eflornithine HCl
-
Charlotte, North CarolinaLevine Children's Hospital
Apr 20, 2022
Non-melanoma Skin Cancer Trial in Birmingham (Solaraze and Vaniqa)
Recruiting
- Non-melanoma Skin Cancer
- Solaraze and Vaniqa
-
Birmingham, Alabama
- +1 more
Nov 14, 2022
Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)
Not yet recruiting
- Diffuse Glioma
- Malignant Glioma
- Biospecimen Collection
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 6, 2023
Pseudofolliculitis Barbae Trial (Eflornithine Topical, Placebo Eflornithine Topical)
Not yet recruiting
- Pseudofolliculitis Barbae
- Eflornithine Topical
- Placebo Eflornithine Topical
- (no location specified)
Jun 22, 2020
Colorectal Cancer, Familial Adenomatous Polyposis Trial in Houston (Celecoxib, Placebo, eflornithine)
Completed
- Colorectal Cancer
- Familial Adenomatous Polyposis
- Celecoxib
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 8, 2020
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)
Active, not recruiting
- Anaplastic Astrocytoma
- Recurrent Anaplastic Astrocytoma
- Eflornithine
- Lomustine
-
Birmingham, Alabama
- +78 more
Jan 19, 2022
Non-melanomatous Skin Cancer Trial (eflornithine)
Completed
- Non-melanomatous Skin Cancer
- eflornithine
- (no location specified)
Dec 12, 2019
Hirsutism Trial (Eflornithine HCl)
Completed
- Hirsutism
- Eflornithine hydrochloride
- (no location specified)
Oct 28, 2019
Colorectal Tumors Trial in United States (Eflornithine & sulindac , eflornithine & sulindac , Eflornithine & sulindac)
Recruiting
- Colorectal Neoplasms
- Eflornithine placebo & sulindac placebo
- +3 more
-
Birmingham, Alabama
- +985 more
Aug 23, 2022
Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
Not yet recruiting
- Hirsutism
- Hair Diseases
- Narcissus Tazetta Bulb Extract and Novel Hemp Extract
- (no location specified)
Aug 15, 2023